Literature DB >> 8680666

Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools.

J F Timsit1, S Chevret, J Valcke, B Misset, B Renaud, F W Goldstein, P Vaury, J Carlet.   

Abstract

The overmortality induced by nosocomial infections, especially pneumonia in ventilated patients (VNP), is still a matter of controversy because it is difficult to know precisely the respective effects of VNP per se and both the underlying illness and the severity of the disease that indicates ICU stay. During a 3-yr period, for each patient mechanically ventilated for more than 48 h we recorded underlying illness, reason for mechanical ventilation, clinical and therapeutic data collected during the first 48 h of ventilation, and death in the ICU. Patients with suspicion of VNP (S-VNP) according to clinical, radiologic, and biologic criteria underwent bronchoscopy with protected specimen brush (PSB) and bronchoalveolar lavage culture (BAL-C). VNP was confirmed (C-VNP) if PSB > or = 10(3) cfu/ml and/or BAL-C > or = 10(4) cfu/ml. Prognostic multivariate analysis was performed introducing S-VNP and C-VNP as time-dependent covariates. Of the 387 studied patients, 112 S-VNP and 56 C-VNP were observed with overall mortality of 43% (168 patients). MacCabe, APACHE II score, shock, use of sedatives and absence of enteral nutrition were additively associated with an increased mortality as well as C-VNP (relative risk [RR]: 1.8, p = 0.007). Nevertheless, when S-VNP and C-VNP were simultaneously introduced in the Cox model, only S-VNP remained associated with increased mortality. In patients suspected of VNP, confirmation of VNP using PSB and/or BAL-C adds no prognostic information. Whether this could be explained by the lack of sensitivity of protected distal samples or the severity of underlying conditions of S-VNP patients is still an open issue. A multivariate analysis based on follow-up data during the ICU course of ventilated patients will be initiated in the near future.

Entities:  

Mesh:

Year:  1996        PMID: 8680666     DOI: 10.1164/ajrccm.154.1.8680666

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

1.  British Thoracic Society guidelines on diagnostic flexible bronchoscopy.

Authors: 
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

2.  Nosocomial or Healthcare Facility-Related Pneumonia in Adults.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-06       Impact factor: 3.725

3.  Diagnosis of ventilator-acquired Pneumonia: Where Do We Go From Here?

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2003-03

Review 4.  Antibacterial treatment of invasive mechanical ventilation-associated pneumonia.

Authors:  F Barcenilla; E Gascó; J Rello; L Alvarez-Rocha
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Pseudomonas aeruginosa induces localized immunosuppression during pneumonia.

Authors:  Maureen H Diaz; Ciara M Shaver; John D King; Srinidhi Musunuri; Jeffrey A Kazzaz; Alan R Hauser
Journal:  Infect Immun       Date:  2008-07-28       Impact factor: 3.441

6.  Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity.

Authors:  Christophe Clec'h; Jean-François Timsit; Arnaud De Lassence; Elie Azoulay; Corinne Alberti; Maite Garrouste-Orgeas; Bruno Mourvilier; Gilles Troche; Muriel Tafflet; Olivier Tuil; Yves Cohen
Journal:  Intensive Care Med       Date:  2004-06-09       Impact factor: 17.440

7.  Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study.

Authors:  G Zanetti; F Bally; G Greub; J Garbino; T Kinge; D Lew; J-A Romand; J Bille; D Aymon; L Stratchounski; L Krawczyk; E Rubinstein; M-D Schaller; R Chiolero; M-P Glauser; A Cometta
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

8.  A 7-year study of severe hospital-acquired pneumonia requiring ICU admission.

Authors:  Jordi Vallés; Eduard Mesalles; Dolors Mariscal; Ma del Mar Fernández; Rocío Peña; José Luis Jiménez; Jordi Rello
Journal:  Intensive Care Med       Date:  2003-09-10       Impact factor: 17.440

9.  Adjusting for time-varying confounding in the subdistribution analysis of a competing risk.

Authors:  Maarten Bekaert; Stijn Vansteelandt; Karl Mertens
Journal:  Lifetime Data Anal       Date:  2009-10-10       Impact factor: 1.588

10.  Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset.

Authors:  J Vallés; A Pobo; O García-Esquirol; D Mariscal; J Real; R Fernández
Journal:  Intensive Care Med       Date:  2007-06-09       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.